ZVSA OTC
ZyVersa Therapeutics, Inc.
1W: -19.2%
1M: -19.4%
3M: -48.1%
YTD: -40.7%
1Y: -44.1%
3Y: -99.8%
$0.08
+0.00 (+0.00%)
Weekly Expected Move ±16.8%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.6M
52W Range0.077-0.3
Volume645
Avg Volume10,666
Beta0.87
Dividend—
Analyst Ratings
Company Info
CEOStephen C. Glover
Employees6
SectorHealthcare
IndustryBiotechnology
IPO Date2022-02-11
Websitezyversa.com
2200 N. Commerce Parkway
Weston, FL 33326
US
Weston, FL 33326
US
754 231 1688
About ZyVersa Therapeutics, Inc.
ZyVersa Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, dedicated to advancing and commercializing therapies for renal (kidney) and inflammatory disorders. The company's pipeline prominently features VAR 200, a cholesterol efflux modulator aimed at addressing kidney diseases such as focal segmental glomerulosclerosis, Alport syndrome, and diabetic kidney disease. Furthermore, ZyVersa is advancing IC 100, a pioneering inflammasome ASC inhibitor positioned to tackle a wide array of inflammatory conditions. The company maintains its corporate headquarters in Weston, Florida.
Latest News
ZyVersa Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
[10-Q] ZyVersa Therapeutics, Inc. Quarterly Earnings Report - Stock Titan
ZyVersa Therapeutics GAAP EPS of -$4.18
ZyVersa Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update
ZyVersa Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Cashmere Karen A. | A-Award | 48,100 | $0.59 | 2025-07-11 |
| Freitag Gregory Gene | A-Award | 11,066 | $0.59 | 2025-07-11 |
| Glover Stephen C. | A-Award | 136,900 | $0.59 | 2025-07-11 |
| Finizio Robert G | A-Award | 11,066 | $0.59 | 2025-07-11 |
| Wolfe Peter | A-Award | 60,100 | $0.59 | 2025-07-11 |